Skip to main content

Peer Review reports

From: Mainstream germline genetic testing in men with metastatic prostate cancer: design and protocol for a multicenter observational study

Original Submission
8 Sep 2022 Submitted Original manuscript
6 Dec 2022 Author responded Author comments - Michiel Vlaming
Resubmission - Version 2
6 Dec 2022 Submitted Manuscript version 2
7 Dec 2022 Editorially accepted
30 Dec 2022 Article published 10.1186/s12885-022-10429-2

You can find further information about peer review here.

Back to article page